1st Quarter - Report

BRACEWELL LLP for UST PUBLIC AFFAIRS INC

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
$30,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report (this page) Apr 19, 2008 $30,000 Replaced
1st Quarter - Amendment Apr 19, 2008 $30,000 Yes

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

H Con Res 312 - FY 2009 Budget Resolution

LobbyistCovered position, as disclosed
JAMES L CHAPMAN Member of Congress (1985-97)
LISA M JAEGER Acting General Counsel, EPA (2003-04)

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Bills named: H.Con.Res. 312 (110th)

Consumer Issues/Safety/Products CSP

S625, S1834, HR1108, HR5513 - FDA Regulation of Tobacco

LobbyistCovered position, as disclosed
JAMES L CHAPMAN Member of Congress (1985-97)
LISA M JAEGER Acting General Counsel, EPA (2003-04)

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: H.R. 5513 (110th), H.R. 1108 (110th)

Agriculture AGR

HR 2932 - Nonmailability of tobacco products

LobbyistCovered position, as disclosed
JAMES L CHAPMAN Member of Congress (1985-97)
LISA M JAEGER Acting General Counsel, EPA (2003-04)

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2932 (110th)

Taxation/Internal Revenue Code TAX

Federal tax increase on tobacco products

LobbyistCovered position, as disclosed
JAMES L CHAPMAN Member of Congress (1985-97)
LISA M JAEGER Acting General Counsel, EPA (2003-04)

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Tobacco TOB

FDA regulation of tobacco, nonmailability of tobacco products S1027 & HR 4081 - tobacco trafficking prevention

LobbyistCovered position, as disclosed
JAMES L CHAPMAN Member of Congress (1985-97)
LISA M JAEGER Acting General Counsel, EPA (2003-04)

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Bills named: H.R. 4081 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.